Chronic protection against ischemia and reperfusion-induced endothelial dysfunction during therapy with different organic nitrates

Clinical Research in Cardiology

Volumn 101, Issue 6, 2012, Pages 453-459

  Lisi, Monica ^a   Oelze, Matthias ^b   Dragoni, Saverio ^a   Liuni, Andrew ^c   Steven, Sebastian ^b   Luca, Mary Clare ^c   Stalleicken, Dirk ^d   Münzel, Thomas ^b   Laghi Pasini, Franco ^a   Daiber, Andreas ^b   Parker, John D ^c   Gori, Tommaso ^b  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^c MOUNT SINAI HOSPITAL   (Canada)

^d Actavis Deutschland GmbH   (Germany)

Author keywords

Endothelial function; Ischemia and reperfusion; Ischemic preconditioning; Nitroglycerin; Pentaerythrityl tetranitrate

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE ISOENZYME 2; GLYCERYL TRINITRATE; ORGANIC NITRATE; PENTAERYTHRITYL TETRANITRATE;

ADULT; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DRUG EFFECT; DRUG REEXPOSURE; DRUG TRANSFORMATION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME INHIBITION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; ISCHEMIC PRECONDITIONING; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY; SINGLE BLIND PROCEDURE; VASODILATATION;

ADULT; ALDEHYDE DEHYDROGENASE; ANALYSIS OF VARIANCE; CELLS, CULTURED; DRUG ADMINISTRATION SCHEDULE; ENDOTHELIUM, VASCULAR; HUMANS; ISCHEMIC PRECONDITIONING; MITOCHONDRIA; NITROGLYCERIN; PENTAERYTHRITOL TETRANITRATE; REPERFUSION INJURY; SINGLE-BLIND METHOD; VASODILATOR AGENTS;

EID: 84863722988     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-012-0412-x     Document Type: Article

References (37)

1. Munzel T, Daiber A, Gori T (2011) Nitrate therapy: new aspects concerning molecular action and tolerance. Circulation 123(19): 2132-2144. doi:10.1161/CIRCULATIONAHA.110.981407
2. Bolli R, Dawn B, Tang XL, Qiu Y, Ping P, Xuan YT, Jones WK, Takano H, Guo Y, Zhang J (1998) The nitric oxide hypothesis of late preconditioning. Basic Res Cardiol 93(5):325-338
3. Szilvassy Z, Ferdinandy P, Nagy I, Jakab I, Koltai M (1997) The effect of continuous versus intermittent treatment with transdermal nitroglycerin on pacing-induced preconditioning in conscious rabbits. Br J Pharmacol 121(3):491-496. doi:10.1038/sj.bjp. 0701163
4. Leesar MA, Stoddard MF, Dawn B, Jasti VG, Masden R, Bolli R (2001) Delayed preconditioning-mimetic action of nitroglycerin in patients undergoing coronary angioplasty. Circulation 103(24): 2935-2941
5. Crisafulli A, Melis F, Tocco F, Pittau G, Lorrai L, Gori T, Mancardi D, Concu A, Pagliaro P (2007) Delayed preconditioning- mimetic actions of exercise or nitroglycerin do not affect haemodynamics and exercise performance in trained or sedentary individuals. J Sports Sci 25(12):1393-1401. doi:10.1080/026404 10601128914
6. Gori T, Di Stolfo G, Sicuro S, Dragoni S, Lisi M, Forconi S, Parker JD (2007) Nitroglycerin protects the endothelium from ischaemia and reperfusion: human mechanistic insight. Br J Clin Pharmacol 64(2):145-150. doi:10.1111/j.1365-2125.2007. 02864.x
7. Dragoni S, Gori T, Lisi M, Di Stolfo G, Pautz A, Kleinert H, Parker JD (2007) Pentaerythrityl tetranitrate and nitroglycerin, but not isosorbide mononitrate, prevent endothelial dysfunction induced by ischemia and reperfusion. Arterioscler Thromb Vasc Biol 27(9):1955-1959. doi:10.1161/ATVBAHA. 107.149278
8. Gori T, Dragoni S, Di Stolfo G, Sicuro S, Liuni A, Luca MC, Thomas G, Oelze M, Daiber A, Parker JD (2010) Tolerance to nitroglycerin-induced preconditioning of the endothelium: a human in vivo study. Am J Physiol Heart Circ Physiol 298(2): H340-H345. doi:10.1152/ajpheart.01324.2008
9. Csont T (2010) Nitroglycerin-induced preconditioning: interaction with nitrate tolerance. Am J Physiol Heart Circ Physiol 298(2):H308-H309. doi:10.1152/ajpheart.01079.2009
10. Schnorbus B, Schiewe R, Ostad MA, Medler C, Wachtlin D, Wenzel P, Daiber A, Munzel T, Warnholtz A (2010) Effects of pentaerythritol tetranitrate on endothelial function in coronary artery disease: results of the PENTA study. Clin Res Cardiol 99(2):115-124. doi:10.1007/s00392-009-0096-z
11. Jurt U, Gori T, Ravandi A, Babaei S, Zeman P, Parker JD (2001) Differential effects of pentaerythritol tetranitrate and nitroglycerin on the development of tolerance and evidence of lipid peroxidation: a human in vivo study. J Am Coll Cardiol 38(3): 854-859
12. Daiber A (2010) Redox signaling (cross-talk) from and to mitochondria involves mitochondrial pores and reactive oxygen species. Biochim Biophys Acta. doi:10.1016/j.bbabio.2010.01.032
13. Chen CH, Budas GR, Churchill EN, Disatnik MH, Hurley TD, Mochly-Rosen D (2008) Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart. Science 321(5895): 1493-1495. doi:10.1126/science.1158554
14. Bartoli G, Menegaz G, Lisi M, Di Stolfo G, Dragoni S, Gori T (2008) Model-based analysis of flow-mediated dilation and intima-media thickness. Int J Biomed Imaging 2008:738545. doi: 10.1155/2008/738545
15. Edgell CJ, McDonald CC, Graham JB (1983) Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci USA 80(12):3734-3737
16. Wenzel P, Hink U, Oelze M, Seeling A, Isse T, Bruns K, Steinhoff L, Brandt M, Kleschyov AL, Schulz E, Lange K, Weiner H, Lehmann J, Lackner KJ, Kawamoto T, Munzel T, Daiber A (2007) Number of nitrate groups determines reactivity and potency of organic nitrates: a proof of concept study in ALDH-2-/- mice. Brit J Pharmacol 150:526-533
17. Beretta M, Sottler A, Schmidt K, Mayer B, Gorren AC (2008) Partially irreversible inactivation of mitochondrial aldehyde dehydrogenase by nitroglycerin. J Biol Chem 283(45):30735-30744. doi:10.1074/jbc.M804001200
18. Ostad MA, Nick E, Paixao-Gatinho V, Schnorbus B, Schiewe R, Tschentscher P, Munzel T, Warnholtz A (2010) Lack of evidence for pleiotropic effects of clopidogrel on endothelial function and inflammation in patients with stable coronary artery disease: results of the double-blind, randomized CASSANDRA study. Clin Res Cardiol 100(1):29-36. doi:10.1007/s00392-010-0199-6
19. Depre C, Park JY, Shen YT, Zhao X, Qiu H, Yan L, Tian B, Vatner SF, Vatner DE (2010) Molecular mechanisms mediating preconditioning following chronic ischemia differ from those in classical second window. Am J Physiol Heart Circ Physiol 299(3):H752-H762. doi:10.1152/ajpheart.00147.2010
20. Shen YT, Depre C, Yan L, Park JY, Tian B, Jain K, Chen L, Zhang Y, Kudej RK, Zhao X, Sadoshima J, Vatner DE, Vatner SF (2008) Repetitive ischemia by coronary stenosis induces a novel window of ischemic preconditioning. Circulation 118(19):1961-1969. doi:10.1161/CIRCULATIONAHA.108.788240
21. Griesberger M, Kollau A, Wolkart G, Wenzl MV, Beretta M, Russwurm M, Koesling D, Schmidt K, Gorren AC, Mayer B (2011) Bioactivation of pentaerythrityl tetranitrate by mitochondrial aldehyde dehydrogenase. Mol Pharmacol 79(3):541-548. doi:10.1124/mol.110.069138
22. Gori T, Munzel T (2009) Symptomatic and hemodynamic benefit of pentaerythrityl tetranitrate and hydralazine in a case of congestive heart failure. Clin Res Cardiol 98(10):677-679. doi: 10.1007/s00392-009-0053-x
23. Daiber A, Wenzel P, Oelze M, Munzel T (2008) New insights into bioactivation of organic nitrates, nitrate tolerance and crosstolerance. Clin Res Cardiol 97(1):12-20. doi:10.1007/s00392-007-0588-7
24. Gori T, Daiber A (2009) Non-hemodynamic effects of organic nitrates and the distinctive characteristics of pentaerithrityl tetranitrate. Am J Cardiovasc Drugs 9(1):7-15. doi:10.2165/00129784-200909010-00002
25. Hink U, Daiber A, Kayhan N, Trischler J, Kraatz C, Oelze M, Mollnau H, Wenzel P, Vahl CF, Ho KK, Weiner H, Munzel T (2007) Oxidative inhibition of the mitochondrial aldehyde dehydrogenase promotes nitroglycerin tolerance in human blood vessels. J Am Coll Cardiol 50(23):2226-2232. doi:10.1016/j.jacc.2007.08. 031
26. Szocs K, Lassegue B, Wenzel P, Wendt M, Daiber A, Oelze M, Meinertz T, Munzel T, Baldus S (2007) Increased superoxide production in nitrate tolerance is associated with NAD(P)H oxidase and aldehyde dehydrogenase 2 downregulation. J Mol Cell Cardiol 42(6):1111-1118. doi:10.1016/j.yjmcc.2007.03.904
27. Chen Z, Foster MW, Zhang J, Mao L, Rockman HA, Kawamoto T, Kitagawa K, Nakayama KI, Hess DT, Stamler JS (2005) An essential role for mitochondrial aldehyde dehydrogenase in nitroglycerin bioactivation. Proc Natl Acad Sci USA 102(34): 12159-12164
28. Ciccone MM, Iacoviello M, Puzzovivo A, Scicchitano P, Monitillo F, De Crescenzo F, Caragnano V, Sassara M, Quistelli G, Guida P, Favale S (2011) Clinical correlates of endothelial function in chronic heart failure. Clin Res Cardiol 100(6): 515-521. doi:10.1007/s00392-010-0275-y
29. Trojnarska O, Szczepaniak-Chichel L, Mizia-Stec K, Gabriel M, Bartczak A, Grajek S, Gasior Z, Kramer L, Tykarski A (2011) Vascular remodeling in adults after coarctation repair: impact of descending aorta stenosis and age at surgery. Clin Res Cardiol 100(5):447-455. doi:10.1007/s00392-010-0263-2
30. Zankl AR, Ivandic B, Andrassy M, Volz HC, Krumsdorf U, Blessing E, Katus HA, Tiefenbacher CP (2010) Telmisartan improves absolute walking distance and endothelial function in patients with peripheral artery disease. Clin Res Cardiol 99(12):787-794. doi:10.1007/s00392-010-0184-0
31. Bulut D, Scheeler M, Niedballa LM, Miebach T, Mugge A (2011) Effects of immunoadsorption on endothelial function, circulating endothelial progenitor cells and circulating microparticles in patients with inflammatory dilated cardiomyopathy. Clin Res Cardiol 100(7):603-610. doi:10.1007/s00392-011-0287-2
32. Karthikeyan VJ, Blann AD, Baghdadi S, Lane DA, Gareth Beevers D, Lip GY (2011) Endothelial dysfunction in hypertension in pregnancy: associations between circulating endothelial cells, circulating progenitor cells and plasma von Willebrand factor. Clin Res Cardiol 100(6):531-537. doi:10.1007/s00392-010- 0277-9
33. Czucz J, Cervenak L, Forhecz Z, Gombos T, Pozsonyi Z, Kunde J, Karadi I, Janoskuti L, Prohaszka Z (2011) Serum soluble E-selectin and NT-proBNP levels additively predict mortality in diabetic patients with chronic heart failure. Clin Res Cardiol 100(7):587-594. doi:10.1007/s00392-011-0283-6
34. Wenzel P, Schulz E, Gori T, Ostad MA, Mathner F, Schildknecht S, Gobel S, Oelze M, Stalleicken D, Warnholtz A, Munzel T, Daiber A (2009) Monitoring white blood cell mitochondrial aldehyde dehydrogenase activity: implications for nitrate therapy in humans. J Pharmacol Exp Ther 330(1):63-71. doi:10.1124/jpet.108.149716
35. Weber W, Michaelis K, Luckow V, Kuntze U, Stalleicken D (1995) Pharmacokinetics and bioavailability of pentaerithrityl tetranitrate and two of its metabolites. Arzneimittelforschung 45(7):781-784
36. Kanamasa K, Naito N, Morii H, Nakano K, Tanaka Y, Kitayama K, Haku R, Kai T, Yonekawa O, Nagatani Y, Ishikawa K (2004) Eccentric dosing of nitrates does not increase cardiac events in patients with healed myocardial infarction. Hypertens Res 27(8):563-572 (pii:JST.JSTAGE/hypres/27.563)
37. Poss J, Jacobshagen C, Ukena C, Bohm M (2011) Hotlines and clinical trial updates presented at the German Cardiac Society Meeting 2010: FAIR-HF, CIPAMI, LIPSIA-NSTEMI, Handheld- BNP, PEPCAD III, remote ischaemic conditioning, CERTIFY, PreSCD-II, German Myocardial Infarction Registry, DiaRegis. Clin Res Cardiol 99(7):411-417. doi:10.1007/s00392-010-0176-0